Skip to Content

Terazosin Pregnancy and Breastfeeding Warnings

Terazosin is also known as: Hytrin

Terazosin Pregnancy Warnings

Terazosin has been assigned to pregnancy category C by the FDA. Animal studies have revealed increased fetal resorption in rats given doses 1,330 times the maximum recommended human dose and increased fetal resorptions, decreased fetal weight, and an increased number of supernumerary ribs in rabbits given doses 165 times the maximum recommended human dose. In addition, postnatal studies in rats given doses greater than 300 times the maximum recommended human dose have revealed increased mortality during the three-week postpartum period relative to controls. There are no controlled data in human pregnancy. Terazosin should only be given during pregnancy when benefit outweighs risk.

See references

Terazosin Breastfeeding Warnings

There are no data on the excretion of terazosin into human milk. The manufacturer recommends that caution be used when administering terazosin to nursing women.

See references

References for pregnancy information

  1. "Product Information. Hytrin (terazosin)." Abbott Pharmaceutical, Abbott Park, IL.

References for breastfeeding information

  1. "Product Information. Hytrin (terazosin)." Abbott Pharmaceutical, Abbott Park, IL.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.